Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Jack G. Modell, MD
PCC
Article
Meta-Analysis of Suicidality in Placebo-Controlled Clinical Trials of Adults Taking Bupropion
September 23, 2010
Read this article to review results from a recent study of the possible relationship between treatment with bupropion and expressed suicidality during clinical trials.
Donna S. Wightman
,
Vicki J. Foster
,
Alok Krishen
, et al
JCP
Original Research
Extended-Release Bupropion for Patients With Major Depressive Disorder Presenting With Symptoms of Reduced Energy, Pleasure, and Interest: Findings From a Randomized, Double-Blind, Placebo-Controlled Study
June 15, 2006
James W. Jefferson
,
A. John Rush
,
J. Craig Nelson
, et al
JCP
Original Research
Bupropion Extended Release Compared With Escitalopram: Effects on Sexual Functioning and Antidepressant Efficacy in 2 Randomized, Double-Blind, Placebo-Controlled Studies.
May 15, 2006
Anita H. Clayton
,
Harry A. Croft
,
Joseph P. Horrigan
, et al
JCP
Original Research
Remission Rates Following Antidepressant Therapy With Bupropion or Selective Serotonin Reuptake Inhibitors: A Meta-Analysis of Original Data From 7 Randomized Controlled Trials
August 15, 2005
Michael E. Thase
,
Barbara R. Haight
,
Nathalie Richard
, et al
PCC
Original Research
A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor
August 13, 2004
Stephen M. Stahl
,
James F. Pradko
,
Barbara R. Haight
, et al